Pleopharma, Inc.

CIK 1801323 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pleopharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 10, 2026D0001801323-26-000001
Aug 8, 2025D0001801323-25-000003
May 6, 2022D0001801323-22-000003
Feb 4, 2020D0001801323-20-000002